Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gajanan Bhat

Pd11-07 Integrated Results of Two Multicenter, Randomized, Placebo Controlled, Double Blind, Phase 3 Trials (Spi-611/612) of Single-Dose Intravesical Apaziquone Immediately Following Resection in Patients With Non-Muscle Invasive Bladder Cancer

Journal of Urology

Urology

2016

English

Effect of Electron Beam and Gamma Rays on Carbon Nanotube Yarn Structure

Materials Research

Mechanics of Materials

Materials Science

Condensed Matter Physics

Mechanical Engineering

2017

English

Related publications

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy

SpringerPlus

Multidisciplinary

2015

English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

Headache

Neurology

2019

English

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

SKIN The Journal of Cutaneous Medicine

2019

English

Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

English

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

The Scientific World Journal

Environmental Science

2011

English

BP-C1 in Treatment of Patients With Stage IV Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study and Additional Open-Label Treatment Phase.

Journal of Clinical Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gajanan Bhat

Pd11-07 Integrated Results of Two Multicenter, Randomized, Placebo Controlled, Double Blind, Phase 3 Trials (Spi-611/612) of Single-Dose Intravesical Apaziquone Immediately Following Resection in Patients With Non-Muscle Invasive Bladder Cancer

Effect of Electron Beam and Gamma Rays on Carbon Nanotube Yarn Structure

Related publications

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

BP-C1 in Treatment of Patients With Stage IV Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study and Additional Open-Label Treatment Phase.